A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 48/00 (2006.01)
Patent
CA 2613889
Compositions and methods applicable to cell-based or regenerative therapy for ophthalmic diseases and disorders comprising mesenchymal stem cells, particularly those characterized by the expression of at least one of the following surface markers: CD29, CD44, CD105 or CD166, and the lack of expression of at least one of CD14, CD34 or CD45.
L'invention concerne des compositions et des procédés servant à la thérapie cellulaire ou régénératrice pour des maladies ou troubles ophtalmiques et comprenant des cellules souches mésenchymateuses, notamment celles caractérisées par l'expression d'au moins un des marqueurs de surface suivants : CD29, CD44, CD105 ou CD166, et par l'absence d'expression d'au moins un marqueur parmi CD14, CD34 ou CD45.
Centocor Inc.
Centocor Ortho Biotech Inc.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
A cellular therapy for ocular degeneration does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with A cellular therapy for ocular degeneration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A cellular therapy for ocular degeneration will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1606771